BRIEF published on 05/06/2025 at 14:08, 1 year 3 months ago Zalando SE maintient une forte croissance au premier trimestre 2025 Acquisition Recommandation D'achat Croissance Des Revenus Zalando SE T1 2025
BRIEF published on 05/06/2025 at 14:06, 1 year 3 months ago Tharimmune Reports Positive Phase 1 Results for TH104 Tharimmune Inc. FDA Feedback Phase 1 Study Opioid Prophylaxis TH104 Buccal Film
BRIEF published on 05/06/2025 at 14:06, 1 year 3 months ago Tharimmune annonce des résultats positifs de phase 1 pour le TH104 Tharimmune Inc. Étude De Phase 1 Commentaires De La FDA Prophylaxie Aux Opioïdes Film Buccal TH104
BRIEF published on 05/06/2025 at 14:05, 1 year 3 months ago Galimedix Therapeutics Completes Phase 1 Study with GAL-101 Alzheimer's Disease Galimedix Therapeutics GAL-101 Phase 1 Study AMD
BRIEF published on 05/06/2025 at 14:05, 1 year 3 months ago Galimedix Therapeutics achève l'étude de phase 1 avec GAL-101 Maladie D'Alzheimer Galimedix Therapeutics Étude De Phase 1 GAL-101 DMLA
BRIEF published on 05/06/2025 at 14:05, 1 year 3 months ago Xifaxan Reduces Risk of 30-Day Rehospitalization After OHE XIFAXAN Chronic Liver Disease OHE Rehospitalization Claims-Based Analysis Lactulose
BRIEF published on 05/06/2025 at 14:05, 1 year 3 months ago Xifaxan réduit le risque de réhospitalisation dans les 30 jours suivant une OHE XIFAXAN Maladie Chronique Du Foie Lactulose Réhospitalisation OHE Analyse Basée Sur Les Réclamations
BRIEF published on 05/06/2025 at 14:05, 1 year 3 months ago MIRA Pharmaceuticals Announces Absence of Neurotoxicity in Ketamir-2 Study Phase I Trial MIRA Pharmaceuticals Ketamir-2 NMDA Receptor Neurotoxicity Study
BRIEF published on 05/06/2025 at 14:05, 1 year 3 months ago MIRA Pharmaceuticals annonce l'absence de neurotoxicité dans l'étude Ketamir-2 Essai De Phase I MIRA Pharmaceuticals Ketamir-2 Récepteur NMDA Étude De Neurotoxicité
BRIEF published on 05/06/2025 at 14:05, 1 year 3 months ago Scepter Holdings, Inc. Welcomes Natalie Guzman to Advisory Board Advisory Board Marketing Strategy Scepter Holdings Natalie Guzman Collegiate Athlete Market
Published on 08/31/2026 at 23:30, 1 hour 5 minutes ago Datametrex Announces Annual and Special Meeting Voting Results
Published on 08/31/2026 at 23:00, 1 hour 35 minutes ago Silver Storm Closes Second and Final Tranche of Non-Brokered Private Placement for Aggregate Gross Proceeds of $21.0 Million
Published on 08/31/2026 at 22:55, 1 hour 40 minutes ago Alset AI Ventures Reports Fiscal Q3 2026 Results, Including $4.1 Million Unrealized, Non-Cash Investment Gain
Published on 08/31/2026 at 22:15, 2 hours 20 minutes ago Namibia Critical Metals Provides Update on Lofdal Joint Venture Transaction
Published on 08/31/2026 at 22:00, 2 hours 35 minutes ago NV Gold Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 08/31/2026 at 22:07, 2 hours 28 minutes ago VIB Vermögen AG with successful Annual General Meeting and effective control and profit transfer agreement
Published on 08/31/2026 at 19:31, 5 hours 4 minutes ago DEAG reports strong results for the first half of 2026
Published on 08/31/2026 at 19:15, 5 hours 20 minutes ago CGTN: How China-Kyrgyzstan 'golden' ties deliver for both nations and the region
Published on 08/31/2026 at 19:00, 5 hours 35 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 24 AOUT 2026 au 28 AOUT 2026
Published on 08/31/2026 at 18:20, 6 hours 15 minutes ago CPI PROPERTY GROUP publishes financial results for the first half of 2026
Published on 08/31/2026 at 18:00, 6 hours 35 minutes ago MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2025/2026
Published on 08/31/2026 at 17:45, 6 hours 50 minutes ago Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 17:45, 6 hours 50 minutes ago Déclaration hebdomadaire d'opérations effectuées du 24 au 28 août 2026
Published on 08/31/2026 at 17:45, 6 hours 50 minutes ago Déclaration hebdomadaire de rachat d'actions
